Podcast Episodes

Back to Search
AUD Medications and Hepatic Safety

In this episode, we explore how liver status shapes medication choice for alcohol use disorder. Dr. Kevin Sevarino breaks down a practical algorithm …

1 month, 2 weeks ago

Short Long
View Episode
GLP-1 Agonists in Serious Mental Illness: Current Evidence

In this episode, we explore whether GLP-1 agonists like semaglutide can tackle the metabolic toll of antipsychotics in schizophrenia. Can a drug famo…

1 month, 3 weeks ago

Short Long
View Episode
Gabapentin, Topiramate & Baclofen in AUD

In this episode, we explore three off-label but evidence-supported medications — gabapentin, topiramate, and baclofen — for alcohol use disorder, exa…

1 month, 4 weeks ago

Short Long
View Episode
Deprescribing Benzodiazepines: When Tapering Might Do More Harm Than Good

In this episode, we explore the nuanced landscape of benzodiazepine tapering, guided by a major 2024 joint clinical practice guideline. Are we traini…

2 months ago

Short Long
View Episode
Disulfiram Unpacked: Efficacy, Risks, and Liver Safety

In this episode, we explore disulfiram (Antabuse), one of the oldest FDA-approved treatments for alcohol use disorder. Dr. Kevin Sevarino breaks down…

2 months, 1 week ago

Short Long
View Episode
GLP-1s and Lithium: What Clinicians Need to Know

In this episode, we explore a surprising drug interaction that every lithium-prescribing clinician should know about: can semaglutide, the widely use…

2 months, 2 weeks ago

Short Long
View Episode
Naltrexone for Alcohol Use Disorder: What You Should Know

In this episode, we explore how naltrexone — the most widely used medication for alcohol use disorder in the US — works, how to dose it safely, and w…

2 months, 2 weeks ago

Short Long
View Episode
The OPTIMUM Trial: A Roadmap for Treatment-Resistant Depression in Late Life

In this episode, we explore the OPTIMUM trial, a landmark study examining how to treat older adults with treatment-resistant depression when antidepr…

2 months, 3 weeks ago

Short Long
View Episode
Difficult-to-Treat Depression: First, Second, and Third-Line Strategies

In this episode, we explore what to do when antidepressants aren't working. How do you systematically approach a patient who isn't getting better — a…

2 months, 4 weeks ago

Short Long
View Episode
Is High-Dose Olanzapine A Clozapine Alternative?

In this episode, we explore whether high-dose olanzapine — beyond the FDA-approved 20 mg ceiling — can be a viable strategy for patients with treatme…

3 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us